Search results
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Pakistan probes distributors of Roche cancer drug after patients go blind
Reuters via Yahoo News· 8 months agoLAHORE, Pakistan (Reuters) -Pakistan said on Monday it was investigating two local distributors of...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
Roche's (RHHBY) MS Drug Meets Goals in the Phase II Study
Zacks via Yahoo Finance· 12 months agoRoche RHHBY announced that the mid-study evaluating investigational oral fenebrutinib in adults with...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Roche's (RHHBY) Application for PNH Drug Accepted by FDA
Zacks via Yahoo Finance· 8 months agoRoche Group RHHBY member Genentech has received a significant boost following the acceptance of its...
Roche diagnostics head to take helm of Swiss pharma giant
Reuters via Yahoo Finance· 2 years ago(Reuters) -Roche's head of diagnostics, Thomas Schinecker, is to take over as group chief executive...
Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
Zacks via Yahoo Finance· 1 year agoShares of Regeneron Pharmaceuticals, Inc. REGN were down 7.69% after the company announced that its...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...